Der #Lungenhochdruck #CTEPH wird oft nicht erkannt. Unbehandelt führt er zum Tod. Die Kerckhoff-Klinik in Bad Nauheim ist das deutsche Zentrum zur Behandlung dieser Krankheit. 👉
www.faz.net/aktuell/rhei...
www.faz.net/aktuell/rhei...
Oft nicht erkannter lebensbedrohlicher Lungenhochdruck CTEPH: Kerckhoff-Klinik in Bad Nauheim hilft Patienten
Fettablagerungen in den Adern haben viele, bei der oft nicht erkannten CTEPH dagegen verstopft Bindegewebe die Lungenarterie. Spezialisten der Kerckhoff-Klinik in Bad Nauheim schälen es heraus – der P...
www.faz.net
September 25, 2026 at 9:25 AM
Der #Lungenhochdruck #CTEPH wird oft nicht erkannt. Unbehandelt führt er zum Tod. Die Kerckhoff-Klinik in Bad Nauheim ist das deutsche Zentrum zur Behandlung dieser Krankheit. 👉
www.faz.net/aktuell/rhei...
www.faz.net/aktuell/rhei...
Dutch cohort: among 140 CTEPH/CTEPD patients with aPL results, 9 (6%) met #APS criteria; 67% had recurrent VTE and 44% were triple-positive. Consistent with guideline-recommended APS screening in CTEPH; numbers were small: pubmed.ncbi.nlm.nih.gov/42712874/ #thrombosis
Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Disease without Pulmonary Hypertension: Prevalence and Clinical Impact in a Dutch Cohort - PubMed
Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disorder associated with venous thromboembolism (VTE) and chronic thromboembolic pulmonary hypertension (CTEPH). Current guidelines recommend APS screening in CTEPH patients. The exact prevalence of APS in both CTEPH and chronic thromboem …
pubmed.ncbi.nlm.nih.gov
September 16, 2026 at 1:43 PM
Dutch cohort: among 140 CTEPH/CTEPD patients with aPL results, 9 (6%) met #APS criteria; 67% had recurrent VTE and 44% were triple-positive. Consistent with guideline-recommended APS screening in CTEPH; numbers were small: pubmed.ncbi.nlm.nih.gov/42712874/ #thrombosis
Have we been wrong about pre-operative therapy in #CTEPH?
On #JHLTThePodcast, we talk with Paula Appenzeller, MD about how findings from the UK CURATE registry can help guide plans for CTEPH patients and post-PEA treatment decisions.
#cardiosky #medsky #pulmsky #pulmonaryvasculardisease
On #JHLTThePodcast, we talk with Paula Appenzeller, MD about how findings from the UK CURATE registry can help guide plans for CTEPH patients and post-PEA treatment decisions.
#cardiosky #medsky #pulmsky #pulmonaryvasculardisease
JHLT the Podcast: Medical therapy pre- and post-pulmonary endarterectomy
Paula Appenzeller is the guest on the JHLT podcast, discussing how findings from the UK CURATE registry challenge assumptions about pre-operative therapy in CTEPH.
www.ishlt.org
September 2, 2026 at 5:18 PM
Have we been wrong about pre-operative therapy in #CTEPH?
On #JHLTThePodcast, we talk with Paula Appenzeller, MD about how findings from the UK CURATE registry can help guide plans for CTEPH patients and post-PEA treatment decisions.
#cardiosky #medsky #pulmsky #pulmonaryvasculardisease
On #JHLTThePodcast, we talk with Paula Appenzeller, MD about how findings from the UK CURATE registry can help guide plans for CTEPH patients and post-PEA treatment decisions.
#cardiosky #medsky #pulmsky #pulmonaryvasculardisease
ERJ Open Research: Early exercise following PEA for CTEPH appears safe and may enhance recovery. Robust trials, standardised protocols and patient-centred approaches are needed to guide best practice and optimise outcomes. https://bit.ly/4rECN6P
Attention Required! | Cloudflare
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL c...
bit.ly
August 16, 2026 at 8:54 AM
ERJ Open Research: Early exercise following PEA for CTEPH appears safe and may enhance recovery. Robust trials, standardised protocols and patient-centred approaches are needed to guide best practice and optimise outcomes. https://bit.ly/4rECN6P
Emerging tools such as dual-energy CT, photon-counting CT, quantitative perfusion assessment, and computational fluid dynamics may help move CTEPH imaging beyond morphology toward functional phenotyping.
buff.ly/2C5Xp4U (Laurent Godinas et al.)
ESR Bridges: chronic thromboembolic pulmonary hypertension: new developments in imaging and treatment—a multidisciplinary view - European Radiology
European Radiology -
buff.ly
August 14, 2026 at 7:00 AM
Emerging tools such as dual-energy CT, photon-counting CT, quantitative perfusion assessment, and computational fluid dynamics may help move CTEPH imaging beyond morphology toward functional phenotyping.
buff.ly/2C5Xp4U (Laurent Godinas et al.)
For radiologists, CTEPH is a powerful example of imaging-driven therapeutic decision-making. Imaging must do more than confirm disease, it needs to map proximal and distal vascular involvement, assess perfusion and haemodynamic impact, and guide multidisciplinary treatment selection.
ESR Bridges: chronic thromboembolic pulmonary hypertension: new developments in imaging and treatment—a multidisciplinary view - European Radiology
European Radiology -
buff.ly
August 14, 2026 at 7:00 AM
For radiologists, CTEPH is a powerful example of imaging-driven therapeutic decision-making. Imaging must do more than confirm disease, it needs to map proximal and distal vascular involvement, assess perfusion and haemodynamic impact, and guide multidisciplinary treatment selection.
CTEPH: where imaging and intervention make a difference 🫁
Chronic thromboembolic pulmonary hypertension is a rare but potentially treatable cause of pulmonary hypertension.
Chronic thromboembolic pulmonary hypertension is a rare but potentially treatable cause of pulmonary hypertension.
ESR Bridges: chronic thromboembolic pulmonary hypertension: new developments in imaging and treatment—a multidisciplinary view - European Radiology
European Radiology -
link.springer.com
August 14, 2026 at 7:00 AM
CTEPH: where imaging and intervention make a difference 🫁
Chronic thromboembolic pulmonary hypertension is a rare but potentially treatable cause of pulmonary hypertension.
Chronic thromboembolic pulmonary hypertension is a rare but potentially treatable cause of pulmonary hypertension.
Every person’s PH journey is different. For those living with CTEPH, the disease brings its own set of challenges and treatment considerations.
Join PHA’s CTEPH Facebook group to connect with patients, share your experience and help others in the PH community.
buff.ly/ARyv5AX
Join PHA’s CTEPH Facebook group to connect with patients, share your experience and help others in the PH community.
buff.ly/ARyv5AX
August 3, 2026 at 9:45 PM
Every person’s PH journey is different. For those living with CTEPH, the disease brings its own set of challenges and treatment considerations.
Join PHA’s CTEPH Facebook group to connect with patients, share your experience and help others in the PH community.
buff.ly/ARyv5AX
Join PHA’s CTEPH Facebook group to connect with patients, share your experience and help others in the PH community.
buff.ly/ARyv5AX
BPA continues to gain momentum, and your voice matters.
The public comment period is now open for the new SCAI/SVM/PERT Consortium Position Statement addressing patient selection, procedural performance, program development, and operator competence.
#BPA #CTEPH
https://ow.ly/olNQ50ZsrLw
The public comment period is now open for the new SCAI/SVM/PERT Consortium Position Statement addressing patient selection, procedural performance, program development, and operator competence.
#BPA #CTEPH
https://ow.ly/olNQ50ZsrLw
July 29, 2026 at 12:00 PM
BPA continues to gain momentum, and your voice matters.
The public comment period is now open for the new SCAI/SVM/PERT Consortium Position Statement addressing patient selection, procedural performance, program development, and operator competence.
#BPA #CTEPH
https://ow.ly/olNQ50ZsrLw
The public comment period is now open for the new SCAI/SVM/PERT Consortium Position Statement addressing patient selection, procedural performance, program development, and operator competence.
#BPA #CTEPH
https://ow.ly/olNQ50ZsrLw
Join us tonight, July 21, at 8 p.m. EDT for our monthly virtual CTEPH Support Group meeting.
Connect with others to discuss challenges and coping strategies to best manage life with #CTEPH.
Register now: buff.ly/Pp9OYwd
Connect with others to discuss challenges and coping strategies to best manage life with #CTEPH.
Register now: buff.ly/Pp9OYwd
July 21, 2026 at 7:01 PM
Join us tonight, July 21, at 8 p.m. EDT for our monthly virtual CTEPH Support Group meeting.
Connect with others to discuss challenges and coping strategies to best manage life with #CTEPH.
Register now: buff.ly/Pp9OYwd
Connect with others to discuss challenges and coping strategies to best manage life with #CTEPH.
Register now: buff.ly/Pp9OYwd
Dr. Oksana Shlobin describes the pulmonary vascular and cardiovascular disease program's interactivity in a new blog: https://www.chestnet.org/newsroom/blog/2026/06/chest-2026-sessions-explore-pulmonary-hypertension-pe-cteph-hfpef-and-more
#PCCM #Pulmonology
#PCCM #Pulmonology
July 20, 2026 at 4:02 PM
Dr. Oksana Shlobin describes the pulmonary vascular and cardiovascular disease program's interactivity in a new blog: https://www.chestnet.org/newsroom/blog/2026/06/chest-2026-sessions-explore-pulmonary-hypertension-pe-cteph-hfpef-and-more
#PCCM #Pulmonology
#PCCM #Pulmonology
Join us now...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 Jul 2026
🕓️ 16:00 BST
Hear from leading experts as they explore the latest in CTEPH genomics, balloon angioplasty, distal pulmonary endarterectomy, and lung transplantation.
➡️ Register and join: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 Jul 2026
🕓️ 16:00 BST
Hear from leading experts as they explore the latest in CTEPH genomics, balloon angioplasty, distal pulmonary endarterectomy, and lung transplantation.
➡️ Register and join: pvrinstitute.org/learning-hub...
July 9, 2026 at 2:55 PM
Join us now...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 Jul 2026
🕓️ 16:00 BST
Hear from leading experts as they explore the latest in CTEPH genomics, balloon angioplasty, distal pulmonary endarterectomy, and lung transplantation.
➡️ Register and join: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 Jul 2026
🕓️ 16:00 BST
Hear from leading experts as they explore the latest in CTEPH genomics, balloon angioplasty, distal pulmonary endarterectomy, and lung transplantation.
➡️ Register and join: pvrinstitute.org/learning-hub...
Still time to register! ⏳️
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
➡️ Register now: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
➡️ Register now: pvrinstitute.org/learning-hub...
July 8, 2026 at 12:34 PM
Still time to register! ⏳️
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
➡️ Register now: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
➡️ Register now: pvrinstitute.org/learning-hub...
📣Review Sharing: Volume 87, Issue 4
🧾Update on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era
👩🔬Cameron Forward,Syed Rehan Quadery
Full Text: imrpress.com/journal/BJHM...
#CTEPH #CTPA #medsky #academicsky
🧾Update on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era
👩🔬Cameron Forward,Syed Rehan Quadery
Full Text: imrpress.com/journal/BJHM...
#CTEPH #CTPA #medsky #academicsky
July 7, 2026 at 8:25 AM
📣Review Sharing: Volume 87, Issue 4
🧾Update on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era
👩🔬Cameron Forward,Syed Rehan Quadery
Full Text: imrpress.com/journal/BJHM...
#CTEPH #CTPA #medsky #academicsky
🧾Update on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era
👩🔬Cameron Forward,Syed Rehan Quadery
Full Text: imrpress.com/journal/BJHM...
#CTEPH #CTPA #medsky #academicsky
PHA’s Quarterly Impact Report highlights how PHA fulfills its mission by giving patients tools to advocate for themselves.
In the latest report, Maryellen Ramstack, a retired nurse who lives with PAH and CTEPH, shares her experience attending Hill Day in 2025.
Learn more: buff.ly/evtrmwG
In the latest report, Maryellen Ramstack, a retired nurse who lives with PAH and CTEPH, shares her experience attending Hill Day in 2025.
Learn more: buff.ly/evtrmwG
July 6, 2026 at 6:05 PM
PHA’s Quarterly Impact Report highlights how PHA fulfills its mission by giving patients tools to advocate for themselves.
In the latest report, Maryellen Ramstack, a retired nurse who lives with PAH and CTEPH, shares her experience attending Hill Day in 2025.
Learn more: buff.ly/evtrmwG
In the latest report, Maryellen Ramstack, a retired nurse who lives with PAH and CTEPH, shares her experience attending Hill Day in 2025.
Learn more: buff.ly/evtrmwG
Next up in our 'Cutting Edge Innovation in Clinical & Experimental PH' series...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
We'll cover key CTEPH developments, from genomics to advanced treatment options.
➡️ Register here: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
We'll cover key CTEPH developments, from genomics to advanced treatment options.
➡️ Register here: pvrinstitute.org/learning-hub...
June 30, 2026 at 11:33 AM
Next up in our 'Cutting Edge Innovation in Clinical & Experimental PH' series...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
We'll cover key CTEPH developments, from genomics to advanced treatment options.
➡️ Register here: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
We'll cover key CTEPH developments, from genomics to advanced treatment options.
➡️ Register here: pvrinstitute.org/learning-hub...
Targeting pathogenic VWF/ADAMTS13 dysregulation attenuates CTEPH progression https://www.biorxiv.org/content/10.64898/2026.06.17.732997v1
June 23, 2026 at 1:00 AM
Targeting pathogenic VWF/ADAMTS13 dysregulation attenuates CTEPH progression https://www.biorxiv.org/content/10.64898/2026.06.17.732997v1
Targeting pathogenic VWF/ADAMTS13 dysregulation attenuates CTEPH progression https://www.biorxiv.org/content/10.64898/2026.06.17.732997v1
June 23, 2026 at 1:00 AM
Targeting pathogenic VWF/ADAMTS13 dysregulation attenuates CTEPH progression https://www.biorxiv.org/content/10.64898/2026.06.17.732997v1
New in Comprehensive Physiology: 🫁 #Oxygen Supplementation Improves Oxygen Uptake Kinetics and #Exercise Performance in #PAH and #CTEPH Patients. 🏋️♂️ https://ow.ly/JrJh50Zb2SK
June 17, 2026 at 1:01 PM
New in Comprehensive Physiology: 🫁 #Oxygen Supplementation Improves Oxygen Uptake Kinetics and #Exercise Performance in #PAH and #CTEPH Patients. 🏋️♂️ https://ow.ly/JrJh50Zb2SK
Join us for the next "Cutting Edge Innovation in Clinical & Experimental PH" session!
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓 16:00 - 17:30 BST
➡️ Register now: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓 16:00 - 17:30 BST
➡️ Register now: pvrinstitute.org/learning-hub...
June 8, 2026 at 10:16 AM
Join us for the next "Cutting Edge Innovation in Clinical & Experimental PH" session!
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓 16:00 - 17:30 BST
➡️ Register now: pvrinstitute.org/learning-hub...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓 16:00 - 17:30 BST
➡️ Register now: pvrinstitute.org/learning-hub...
For inoperable/residual CTEPH, plasma sST2 and IL-6 are powerful, independent prognostic biomarkers. Their combined use creates a strong risk gradient and significantly improves existing risk models, paving the way for personalised treatment strategies. https://bit.ly/4qNZzsm
June 6, 2026 at 3:53 PM
For inoperable/residual CTEPH, plasma sST2 and IL-6 are powerful, independent prognostic biomarkers. Their combined use creates a strong risk gradient and significantly improves existing risk models, paving the way for personalised treatment strategies. https://bit.ly/4qNZzsm
The #ISHLT-endorsed 2026 International CTEPH Conference takes place this month in Warsaw, Poland. #ICC2026 is one of the leading scientific meetings dedicated to #CTEPH and related #thromboembolic diseases. 💡💸Standard registration rates are available through 5 June: 🔗 https://bit.ly/4fWoBmR
June 2, 2026 at 4:57 PM
The #ISHLT-endorsed 2026 International CTEPH Conference takes place this month in Warsaw, Poland. #ICC2026 is one of the leading scientific meetings dedicated to #CTEPH and related #thromboembolic diseases. 💡💸Standard registration rates are available through 5 June: 🔗 https://bit.ly/4fWoBmR
Canadian #CTEPH patient, Carol Stokley was healthy, active, and unstoppable until the day she couldn’t breathe. After months of being told nothing was wrong, she collapsed with life-threatening clots in her lungs. @phaware.bsky.social podcast ep 575 @phacanada medium.com/p/im-aware-t...
I’m Aware That I’m Rare: Carol Stokely (575)
the phaware® interview
medium.com
June 2, 2026 at 2:19 PM
Canadian #CTEPH patient, Carol Stokley was healthy, active, and unstoppable until the day she couldn’t breathe. After months of being told nothing was wrong, she collapsed with life-threatening clots in her lungs. @phaware.bsky.social podcast ep 575 @phacanada medium.com/p/im-aware-t...
The New Era of CTEPH Care. Dr. Jenny Yang explains how new testing and team-based care are solving one of pulmonary medicine’s most overlooked mysteries and changing what’s possible for CTEPH patients. Sponsored by Liquidia. https://phawarepodcast.libsyn.com/site/episode-574-jenny-yang-md
May 28, 2026 at 3:30 PM
The New Era of CTEPH Care. Dr. Jenny Yang explains how new testing and team-based care are solving one of pulmonary medicine’s most overlooked mysteries and changing what’s possible for CTEPH patients. Sponsored by Liquidia. https://phawarepodcast.libsyn.com/site/episode-574-jenny-yang-md
Jenny Yang, MD explains how new testing and team-based care are solving one of pulmonary medicine’s most overlooked mysteries and what’s possible for #CTEPH patients. @phaware.bsky.social podcast ep 574 #phawareMD @ucsdhealth.bsky.social @JennyYangMD #Liquidia. phaware.medium.com/im-aware-tha...
I’m Aware That I’m Rare: Jenny Yang, MD (574)
the phaware® interview
phaware.medium.com
May 26, 2026 at 2:55 PM
Jenny Yang, MD explains how new testing and team-based care are solving one of pulmonary medicine’s most overlooked mysteries and what’s possible for #CTEPH patients. @phaware.bsky.social podcast ep 574 #phawareMD @ucsdhealth.bsky.social @JennyYangMD #Liquidia. phaware.medium.com/im-aware-tha...